Abstract
Neurodivergent (ND) individuals (e.g., Autistic people) are more likely to experience health problems that are characterised by central sensitisation ’. Recent research suggests that a so-called ‘Long-COVID’ syndrome might also be explained by a heightened response to internal physiological stimuli, much like in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Using a standardised assessment tool, we examined whether traits associated with Autism would predict long-term COVID-19 symptoms in 267 Healthcare Workers (HCW).. Higher autistic traits predicted COVID-19 symptoms that lasting more than 12 weeks regardless of formal autism diagnosis. A personality measure also showed that negative affect was associated with experiencing COVID-19 symptoms for 4-12 weeks, though the direction of causality in this case is uncertain. Limitations of the present study are 1) the retrospective nature of COVID-19 symptom reporting; 2) likely self-selection bias given the high number of HCWs who reported long-term COVID-19 symptoms; and 3) the gender-bias towards females in our sample.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The CHOIS study was supported by the North East and North Cumbria Academic Health Sciences Network (AHSN; fund awarded to co-author DRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cambridge East Research Ethics Committee approved this study (Ethics Ref: 20/EE/0161), which was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of Abbreviations
- AB
- Antibody
- AC
- Acute COVID-19
- CS
- Central Sensitisation
- DS14
- Type D Personality Scale
- HCWs
- Healthcare Workers
- IBS
- Irritable Bowel Syndrome
- LFT
- Lateral Flow Test
- ME/CFS
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- ND
- Neurodivergent/Neurodivergence
- OSC
- Ongoing Symptomatic COVID-19
- PCR
- Polymerase Chain Reaction
- PCS
- Post-COVID-19 Syndrome
- RAADS
- Ritvo Autism & Asperger Diagnostic Scale
- SOB
- Shortness of Breath
- TDP
- Type D Personality
